Andrew Witty News
-
GlaxoSmithKline Plc, the U.K.’s largest drugmaker, said first-quarter profit fell 6 percent after losing revenue from several products it divested.
-
GlaxoSmithKline Plc Chief Executive Officer Andrew Witty plans to announce two “small” acquisitions soon, after walking away from five potential purchases or partnerships since October.
-
GlaxoSmithKline Plc is adding new products in China and hiring “a few hundred” more salespeople to promote them, betting that health-care reforms will widen access to drugs and make up for state-mandated price cuts.
-
GlaxoSmithKline Plc is having a tougher time than expected generating sales in Europe as the credit crisis leads governments to cut prices, Chief Executive Officer Andrew Witty said.
-
GlaxoSmithKline Plc, the U.K.’s largest drugmaker, reported first-quarter profit and sales that missed analyst estimates as revenue declined in Europe.
-
GlaxoSmithKline Plc named Simon Dingemans , a Goldman Sachs Group Inc. investment banker, as chief financial officer at a time when the U.K. drugmaker is counting on acquisitions to help boost sales.
-
GlaxoSmithKline Plc , the U.K.’s biggest drugmaker, reported a 14 percent increase in first- quarter profit, helped by a gain from the sale of its stake in Quest Diagnostics Inc.
-
GlaxoSmithKline Plc, the U.K.’s largest drugmaker, said sales and profit will rise this year as the company awaits regulators’ approval of six drugs.
-
GlaxoSmithKline Plc Chief Executive Officer Andrew Witty and former Tesco Plc Chairman David Reid were given knighthoods in a U.K. honors list that also includes golfers Darren Clarke and Rory McIlroy.
-
Six months ago, Roberto Solari talked eagerly about his research into the mechanisms that govern asthma. Now he must let someone else finish the job.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page